Evidence mapPaperPMID 42367741Full record

ArticleBiophysics reports2026

Quantifying telomere length: from bulk assays to single-molecule resolution.

Kangkang Ma, Zhongbo Yu

Abstract read
In one paragraph

Article in Biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kangkang MaState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China.
Zhongbo YuState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomere length (TL) is a promising biomarker for age-associated diseases and cancer. Single-molecule studies of human TL are advancing rapidly, providing unprecedented insights into the dynamics and variability of telomeres at the single-molecule level. TL is commonly reported as average TL or relative TL, depending on the methods used. However, average TL, short TL, and long TL have distinct significances: average TL serves as a general biomarker for aging, short TL indicates the risk of age-related diseases, and long TL is associated with certain cancers and all-cancer mortality. Thus, the TL distribution is more important than the average TL alone. Single-molecule techniques measure TL one telomere at a time, offering quantitative TL distributions that are crucial for understanding telomere biology. In this review, we focus on various TL measurement techniques, with particular emphasis on single-molecule methods. Single-molecule studies of human TL are poised to play a pivotal role in advancing our understanding and clinical management of age-associated diseases and cancer.

Indexed as

Magnetic tweezersNanoporeSingle-moleculeTelomere lengthTerminal restriction fragments

Identifiers

PMID42367741
PMCPMC13294200

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.